Article Listing - Celgene to drop Revlimid in CR prostate cancer following Ph III trial failure

WHO BUDGET CRISIS IMPACT ON STAFF

6 April 1992

Staff of the World Health Organiz-ation, as a result of the budget crisis, are "deeply concerned not only about their...

ARAB PHARMA COOPERATION

6 April 1992

The executive board of the Union of Arab Druggists, meeting in Cairo, has established a new system of cooperation in...

GERMAN COMPANIES REACT TO BKA WARNING

6 April 1992

Two leading German drug wholesalers, Gehe of Stuttgart and Sanacorp of Bavaria, have reacted sharply to the recent warning by...

NICOTINELL TTS LAUNCHED IN FRANCE

6 April 1992

Ciba-Geigy has launched its transdermal nicotine patch, Nicotinell TTS, onto the French market. The smoking cessation product is also comarketed...

FURTHER FALLS FOR DEPRENYL?

6 April 1992

Shares of the Canadian biopharmaceutical company Deprenyl Re-search have recently lost value and could well fall further, according to local...

NEW PRES AT PROCORDIA

6 April 1992

Jan Ekberg has been named as president and chief executive at Procordia, in succession to Soren Gyll who has become...

US PHARMACY COMPOUNDING GUIDE

6 April 1992

The US Food and Drug Administration has, for the first time, issued a pharmacist compounding compliance guide, due to the...

MAINTENANCE ULCER THERAPY CUT URGED

6 April 1992

A team of UK gastroenterologists have called for physicians to stop treating duodenal ulcer patients with maintenance H2 antagonist therapy....

ROMANIAN HEALTH SECTOR PLANS

6 April 1992

Romania's Minister of Health, Mircea Aiorescu, has announced in Bucharest that his Ministry is planning to change various aspects of...

SIEMENS IN ALBANIA

30 March 1992

Siemens of Germany will play an increasingly important role in the development of medicines in Albania, reports the Albanian Telegraphic...

Showing 94541-94550 of 95356 articles

Go to beginningPreviousNextGo to end